ADAPTING TO THE COVID ERA

Quarantined, lockdowns, Social distancing are features of the new normal. Everyone in the country is affected one way or the other. Key to coming out of C-19 and perhaps future C-19+x's is an adaptation to the new normal. The Ortho-Neurosspine medical device markets might consider the following:

1.  Minimize movement of instruments sets from one hospital or ASC to another. 
2. Sterile implant and instrument kits.  
3. Implement virtual Ortho-surgical tech education and training. Company device reps presence in the ORs will be under scrutiny.
4. Be prepared for price concessions if a hospital or ASC decides to take ownership and manage without device reps to assure patient safety.

Marketing and engineering teams, time get the creative juices running full tilt.

• Marketing new messaging, the company will address the new normal. It will not be business as usual for some time, if ever again.
• R&D Engineering, time to take a hard look at instruments, products, and manufacturing processes. Can product OR workflows be simplified,  " Are all those complex widgets needed?"  How can the cost of instrument sets be reduced so the company can park sets in ORs?

Supply Chain:

• Time to expand the supply chain in the USA, we need to put displaced USA citizens in stable manufacturing positions.

Executive teams, It's time for innovation, communication more than ever to customers, patients, and both external and internal organizational teams. The coming months requires sound leadership, revenues took a hit in March-April, forecasted to continue for the foreseeable future, shareholders will be nervous. Lead with clear messaging, avoid the month to month sales syndrome, and reassure all the stakeholders you have their back.